Dova Pharmaceuticals Inc.: key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2018)
- $10.4M
- Net Income/Loss (FY2018)
- -$72.3M
- Total Assets (FY2018)
- $112.2M
- Total Equity (FY2018)
- $76.4M
- Cash Flows from Operating Activities (FY2018)
- -$53.7M
Source: Dova Pharmaceuticals Inc. 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
